Press Briefing - Efficacy and safety of the authorised mRNA vaccines against COVID-19 on Thursday, 14 January 2021, 11 a.m. – 12 p.m.
Presentation | Prof Klaus Cichutek, Paul-Ehrlich-Institut: COVID-19 vaccine products authorised in Germany and the EU –Quality, safety, and efficacy (14 January 2021) (German only)
Presentation | Dr Brigitte Keller-Stanislawski, Paul-Ehrlich-Institut: COVID-19 vaccine products authorised in Germany and the EU – Safety and efficacy (14 January 2021) (German only)
Information for the Media
If you are a journalist, please contact the press office of the Paul-Ehrlich-Institut. Please understand that the press office can only answer inquiries from media representatives.
!!!We are receiving increased media attention and kindly ask you to send your questions preferable by email to our press team!!!
Phone: +49 6103 77 1030
Head of Public Relations and Press Spokeswoman